EMA Authorised: Trepulmix (treprostinil sodium) — SciPharm Sàrl

View source ↗

Summary

The European Medicines Agency authorised Trepulmix (treprostinil sodium) for the treatment of pulmonary arterial hypertension and it carries orphan medicine des…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Trepulmix (treprostinil)

Snippet

Status: Authorised. Therapeutic area: Hypertension, Pulmonary. MAH: SciPharm Sàrl. Decision date: 30/07/2025. Orphan medicine